Top conditions
Top treatments
Data sourced from clinicaltrials.gov
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
This is a randomized, double-blind, placebo-controlled, repeat-dose, multicenter trial. Participants will be screened within 6 weeks prior to the Bas...
The purpose of this study is to assess the safety and efficacy of tulisokibart in participants with SSc-ILD.
Clinical trials
Research sites
Resources
Legal